Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H23NO2 |
| Molecular Weight | 237.3379 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CC1=CC(C)=CC(=O)N1O)CC(C)(C)C
InChI
InChIKey=OIQJEQLSYJSNDS-UHFFFAOYSA-N
InChI=1S/C14H23NO2/c1-10-6-12(15(17)13(16)8-10)7-11(2)9-14(3,4)5/h6,8,11,17H,7,9H2,1-5H3
| Molecular Formula | C14H23NO2 |
| Molecular Weight | 237.3379 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Piroctone olamine is used in combination with other substances as a part of shampoo effectively reduced the amount of dandruff and, at the same time, provided hair conditioning advantages. Recently was shown, that piroctone olamine could induce apoptosis and possessed a significant in vivo effect against myeloma.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21282741 |
Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Allergic contact dermatitis to propyl gallate and pentylene glycol in an emollient cream. | 2010-05 |
|
| The in vitro effect of a collagenolytic enzyme inhibitor on lesion development in root dentin. | 2009-04 |
|
| Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial. | 2008-03 |
|
| In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans. | 2006-05 |
|
| [Determination of antidangdruff agent salicylic acid, zinc pyrithione, octopirox, climbazole and ketoconazole in shampoo by high performance liquid chromatography]. | 2005-09 |
|
| In vitro antimycotic activity and nail permeation models of a piroctone olamine (octopirox) containing transungual water soluble technology. | 2005 |
|
| Enhanced delivery of an anti-dandruff active in a shampoo vehicle. | 2004 |
|
| Effect of residence time on the efficacy of antidandruff shampoos. | 2003-12 |
|
| Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations. | 2002-10 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21272039
shampoo
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21282741
Curator's Comment: It was demonstrated, that piroctone olamine had a major apoptotic activity in various human and murine myeloma and lymphoma cell lines, as well as in human primary cells.
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:26:45 GMT 2025
by
admin
on
Mon Mar 31 18:26:45 GMT 2025
|
| Record UNII |
R49EFA73Q7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C78284
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
R49EFA73Q7
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
R49EFA73Q7
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
50259
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
50650-76-5
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
4808
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
2058907
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
59009
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
DTXSID2048298
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
SUB09927MIG
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
CHEMBL1473700
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
3479
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
100000081694
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
C66429
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | |||
|
m8885
Created by
admin on Mon Mar 31 18:26:45 GMT 2025 , Edited by admin on Mon Mar 31 18:26:45 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |